A Trial of Enteral Colostrum on Clinical Outcomes in Critically Ill Patients

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 15, 2017

Primary Completion Date

November 7, 2018

Study Completion Date

November 7, 2018

Conditions
Critical IllnessInfection ComplicationMultiple Organ Dysfunction Syndrome
Interventions
DIETARY_SUPPLEMENT

Colostrum

Enteral colostrum 20g/day powdered colostrum to be mixed in with water and given via nasogastric tube q4 hrs.

DIETARY_SUPPLEMENT

Maltodextrin

Maltodextrin mixed with water given via NG tube Q 4 hours.

Trial Locations (1)

Unknown

National Nutrition and Food Technology Research Institute, Tehran

All Listed Sponsors
lead

National Nutrition and Food Technology Institute

OTHER

NCT03019250 - A Trial of Enteral Colostrum on Clinical Outcomes in Critically Ill Patients | Biotech Hunter | Biotech Hunter